vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does vTv Therapeutics (VTVT) operate in?

vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 6.75K
Day Range	- - -
52 Wk Range	7.38 - 31.20
Market Cap	$45.81M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	2.52%
Days to Cover	5.59

Recent News

S&P 500 Edges Lower; ADT Posts Upbeat Earnings

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92.

Avi Kapoor

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Avi Kapoor

Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?

vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on cadisegliatin for type 1 diabetes. Stock up 111.8% at $18.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About vTv Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of ora...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy vTv Therapeutics (VTVT) stock?

You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.

View our list of the best stock brokerages

Who are vTv Therapeutics (VTVT) competitors?

Other companies in vTv Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), BioLine Rx (NASDAQ:BLRX) and Cue Biopharma (NASDAQ:CUE).

What is the target price for vTv Therapeutics (VTVT) stock?

There is no analysis for vTv Therapeutics.

What is the forecast for vTv Therapeutics (VTVT) stock?

vTv Therapeutics has a consensus price target of $4.33.

Current stock price for vTv Therapeutics (VTVT)?

The stock price for vTv Therapeutics (NASDAQ: VTVT) is $18.8284 last updated June 21, 2024 at 4:16 PM EDT.

Does vTv Therapeutics (VTVT) pay a dividend?

There are no upcoming dividends for vTv Therapeutics.

When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?

vTv Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.

Is vTv Therapeutics (VTVT) going to split?

There is no upcoming split for vTv Therapeutics.

What sector and industry does vTv Therapeutics (VTVT) operate in?

vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

vTv Therapeutics

vTv Therapeutics (VTVT) Forecast